Northern Trust Corp Opgen Inc Transaction History

Northern Trust Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.0 - $2.94 $1,264 - $3,716	-1,264 Reduced 1.78%	69,789 $70,000
Q3 2021 Nov 15, 2021	SELL	$2.18 - $3.58 $2,299 - $3,776	-1,055 Reduced 1.46%	71,053 $205,000
Q2 2021 Aug 13, 2021	BUY	$1.95 - $2.8 $58,626 - $84,182	30,065 Added 71.51%	72,108 $164,000
Q1 2021 May 12, 2021	BUY	$1.8 - $3.55 $1,546 - $3,049	859 Added 2.09%	42,043 $105,000
Q4 2020 Feb 11, 2021	BUY	$1.7 - $2.47 $9,450 - $13,730	5,559 Added 15.6%	41,184 $84,000
Q3 2020 Nov 16, 2020	BUY	$1.98 - $3.37 $2,669 - $4,542	1,348 Added 3.93%	35,625 $76,000
Q2 2020 Aug 14, 2020	BUY	$1.88 - $2.59 $64,440 - $88,777	34,277 New	34,277 $70,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $40.3M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.